浏览全部资源
扫码关注微信
1.北京中医药大学第二临床医学院,北京 100029
2.北京中医药大学东方医院肿瘤科,北京 100078
徐婕,女,26岁,硕士研究生。研究方向:中西医结合防治恶性肿瘤。
周天,E-mail:zhoutian_med@163.com
收稿日期:2024-10-30,
纸质出版日期:2025-04-25
移动端阅览
徐婕,于敏,朱慧蓉,等.基于痰瘀伏邪理论探讨冷冻消融术后肿瘤复发的中医治疗[J].北京中医药,2025,44(4):500-503.
XU Jie,YU Min,ZHU Huirong,et al.TCM treatment of tumor recurrence after cryoablation based on the theory of phlegm-stasis and latent evils[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(04):500-503.
徐婕,于敏,朱慧蓉,等.基于痰瘀伏邪理论探讨冷冻消融术后肿瘤复发的中医治疗[J].北京中医药,2025,44(4):500-503. DOI: 10.16025/j.1674-1307.2025.04.023.
XU Jie,YU Min,ZHU Huirong,et al.TCM treatment of tumor recurrence after cryoablation based on the theory of phlegm-stasis and latent evils[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(04):500-503. DOI: 10.16025/j.1674-1307.2025.04.023.
冷冻消融后常有肿瘤细胞残留,残留的肿瘤细胞是痰瘀伏邪的微观体现,若未及时施治,痰瘀伏邪积聚日久而自发,或卫气不足,风邪侵袭引动伏邪,导致肿瘤复发。基于痰瘀伏邪理论,肿瘤冷冻消融术后治疗应以化痰散瘀、搜剔伏邪为基础,避免痰瘀伏邪积聚、深入;益气固表、祛风散邪贯穿治疗始终,以顾护机体免于外邪侵扰而引动伏邪;在冷冻消融后的巩固治疗阶段,以调和气血、平衡阴阳为关键,意在提高长期疗效。
After cryoablation, residual tumor cells are common. These residual tumor cells are the microscopic manifestation of phlegm and blood stasis as latent evils. If not treated in time, the accumulation of phlegm and blood stasis will spontaneously manifest over time, or insufficient defense
qi
and th
e invasion of wind evil may trigger latent evils, leading to tumor recurrence. Based on the theory of phlegm-stasis and latent evils, the treatment after tumor cryoablation should focus on resolving phlegm, dispersing blood stasis, and eliminating latent evils to prevent their accumulation and deepening. Strengthening
qi
and consolidating the surface, as well as dispelling wind and dissipating evil, should be integrated throughout the treatment to protect the body from external evils that may trigger latent evils. In the consolidation treatment phase after cryoablation, the key is to harmonize
qi
and blood and balance
yin
and
yang
, aiming to improve the long-term therapeutic effect.
TAN E , CHONG J , PUA U , et al . Local recurrence and residual tumor rates following cryoablation for small early-stage breast cancers:systemic review and meta-analysis [J ] . Breast Cancer , 2025 , 32 ( 1 ): 69 - 78 .
VAN DEN BIJGAART R , SCHUURMANS F , FÜTTERER JJ , et al . immune modulation plus tumor ablation:adjuvants and antibodies to prime and boost anti-tumor immunity in situ [J ] . Front Immunol , 2021 ( 12 ): 617365 .
时克 , 黄云义 , 侯杰 , 等 . 扶正解毒方药调节肝癌微环境作用机制研究进展 [J ] . 北京中医药 , 2020 , 39 ( 12 ): 1321 - 1323 .
沈洋 , 孙韬 , 李泉旺 , 等 . 中药联合氩氦刀“绿色治疗”模式对44例老年晚期非小细胞肺癌患者的生存影响 [J ] . 环球中医药 , 2016 , 9 ( 1 ): 29 - 33 .
贾博超 , 胡元会 , 杜宜航 , 等 . 基于“伏邪”理论探讨阵发性心房颤动的病机与诊疗思路 [J ] . 北京中医药 , 2024 , 43 ( 3 ): 299 - 304 .
BAUST JG , SNYDER KK , SANTUCCI KL , et al . Cryoablation:physical and molecular basis with putative immunological consequences [J ] . Int J Hyperthermia , 2019 , 36 ( sup1 ): 10 - 16 .
KROEZE SG , VAN MELICK HH , NIJKAMP MW , et al . Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model [J ] . BJU Int , 2012 , 110 ( 6 Pt B ): E281 - E286 .
JING X , YANG F , SHAO C , et al . Role of hypoxia in cancer therapy by regulating the tumor microenvironment [J ] . Mol Cancer , 2019 , 18 ( 1 ): 157 .
KATO T , IWASAKI T , UEMURA M , et al . Characterization of the cryoablation-induced immune response in kidney cancer patients [J ] . Oncoimmunology , 2017 , 6 ( 7 ): e1326441 .
YANG X , GUO Y , GUO Z , et al . Cryoablation inhibition of distant untreated tumors(abscopal effect)is immune mediated [J ] . Oncotarget , 2019 , 10 ( 41 ): 4180 - 4191 .
GRETEN FR , GRIVENNIKOV SI . Inflammation and cancer:triggers, mechanisms, and consequences [J ] . Immunity , 2019 , 51 ( 1 ): 27 - 41 .
梁亮 , 甘芷川 , 何妍婷 , 等 . 西黄丸/胶囊联合现代医学治疗消化系统肿瘤的研究进展 [J ] . 广西医科大学学报 , 2023 , 40 ( 7 ): 1237 - 1243 .
张珂洋 , 张永清 , 杨春淼 , 等 . 全蝎的炮制历史沿革、化学成分及药理作用研究进展 [J ] . 中国中药杂志 , 2024 , 49 ( 4 ): 868 - 883 .
袁琴 , 姚霏 , 张露蓉 , 等 . 玉屏风散对肝癌微环境中血管生成的调节机制 [J ] . 南京中医药大学学报 , 2020 , 36 ( 2 ): 205 - 210 .
钟睿康 , 胡凯文 , 周天 . 胡凯文分期论治肺癌经验 [J ] . 北京中医药 , 2023 , 42 ( 12 ): 1327 - 1330 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构